A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection, Nat Med, vol.16, pp.334-338, 2010. ,
An in vitro assay to study chikungunya virus RNA synthesis and the mode of action of inhibitors, J Gen Virol, vol.95, pp.2683-2692, 2014. ,
Trigocherrierin A, a potent inhibitor of chikungunya virus replication, Molecules, vol.19, pp.3617-3627, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01011997
A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus, Vaccine, vol.31, pp.3718-3725, 2013. ,
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial, Lancet, vol.384, issue.9959, pp.2046-2052, 2011. ,
A chimeric vesiculo/alphavirus is an effective alphavirus vaccine, J Virol, vol.87, pp.395-402, 2013. ,
an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection, J Virol, vol.89, pp.581-593, 2015. ,
A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease, PLoS Pathog, vol.4, issue.2, p.29, 2008. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402310
Prophylaxis and therapy for Chikungunya virus infection, J Infect Dis, vol.200, pp.516-523, 2009. ,
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218, Am J Trop Med Hyg, vol.62, pp.681-685, 2000. ,
Severe disease manifestations associated with Acute chikungunya virus infection, Crit Care Med, vol.36, issue.9, pp.2682-2683, 2008. ,
The cost of chikungunya to Jamaica. Jamaica Observer, 2014. ,
Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice, J Virol, vol.88, pp.2858-2866, 2014. ,
Reappearance of chikungunya, formerly called dengue, Americas. Emerg Infect Dis, vol.21, pp.557-561, 2015. ,
Production and evaluation of a formalin-killed Chikungunya vaccine, J Immunol, vol.107, pp.643-647, 1971. ,
Chikungunya disease outbreak, Reunion Island, Emerg Infect Dis, vol.12, issue.2, pp.1994-1995, 2006. ,
Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression, Antimicrob Agents Chemother, vol.57, pp.155-167, 2013. ,
Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells, J Med Virol, vol.82, pp.817-824, 2010. ,
Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages, J Clin Invest, vol.120, issue.3, pp.894-906, 2010. ,
Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in, Crit Care Med, vol.36, issue.9, pp.2536-2541, 2005. ,
Development of an attenuated strain of chikungunya virus for use in vaccine production, Vaccine, vol.4, pp.157-162, 1986. ,
A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates, PLoS Negl Trop Dis, vol.5, issue.928, 2011. ,
Increased mortality rate associated with chikungunya epidemic, Emerg Infect Dis, vol.14, issue.3, pp.412-415, 2008. ,
Reemergence of chikungunya virus, J Virol, vol.88, pp.11644-11647, 2014. ,
Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanism, PLoS Pathog, vol.7, issue.1002142, 2011. ,
Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays, PLoS One, vol.6, 2011. ,
Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-inman trial, Lancet Infect Dis, vol.15, issue.5, pp.519-527, 2015. ,
Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose, J Infect Dis, vol.209, pp.1891-1899, 2014. ,
Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis, J Infect Dis, vol.204, pp.1026-1030, 2011. ,
Type I IFN controls chikungunya virus via its action on non-hematopoietic cells, J Exp Med, vol.207, issue.2, pp.429-442, 2010. ,
Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study, PLoS Negl Trop Dis, vol.7, issue.3, p.2137, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01189712
The chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study, PLoS Negl Trop Dis, vol.5, issue.6, p.1197, 2011. ,
Prospective study of Chikungunya virus acute infection in the Island of La Reunion during the 2005-2006 outbreak, PLoS One, vol.4, issue.10, p.7603, 2009. ,
Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, PLoS Negl Trop Dis, vol.7, issue.1, p.2004, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01307675
Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy, Antiviral Res, vol.99, issue.3, pp.345-370, 2013. ,
DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice, J Infect Dis, vol.209, pp.1882-1890, 2014. ,
Chimeric alphavirus vaccine candidates for chikungunya, Vaccine, vol.26, pp.5030-5039, 2008. ,
Chikungunya: evolutionary history and recent epidemic spread, Antiviral Res, vol.120, pp.32-39, 2015. ,
Virologists form Global Virus Response Network, Nature News Blog, 2011. ,